E Jagoda

High resolution PET, SPECT and projection imaging in small animals.

W C Eckelman, J J Vaquero, M V Green, 2001, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

Development of fluorine-18-labeled 5-HT1A antagonists.

W C Eckelman, R E Carson, E Jagoda, 1999, Journal of medicinal chemistry.

Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907

W C Eckelman, R E Carson, H Watabe, 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.

W C Eckelman, E Jagoda, I. Pastan, 1997, Bioconjugate chemistry.

Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.

W C Eckelman, E Jagoda, W. Eckelman, 1999, Cancer research.

PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.

W C Eckelman, R E Carson, H Watabe, 2000, Nuclear medicine and biology.

Fluoro analogs of WAY-100635 with varying pharmacokinetics properties.

W C Eckelman, E Jagoda, W. Eckelman, 2000, Nuclear medicine and biology.

Muscarinic Cholinergic Receptor Measurements with [18F]FP-TZTP: Control and Competition Studies

W C Eckelman, R E Carson, E Jagoda, 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes.

M Der, W C Eckelman, E Jagoda, 2001, Journal of chromatography. B, Biomedical sciences and applications.